What are Vir Biotechnology, Inc.'s profit margins?

Gross margin is 96.1% and operating margin is -720.8%, with a -676.0% net margin.

Where does Vir Biotechnology, Inc.'s income statement data come from?

Every line is extracted from Vir Biotechnology, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Vir Biotechnology, Inc. VIR Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Total revenue	-$29K-100%	$64.07M+26,596%	$240K-80.2%	$1.21M-60.0%	$3.03M-75.5%
Gross profit	——	——	——	$1.2M-60.3%	$3.03M-74.1%
Research and development	$108.92M+23.3%	$88.35M-41.7%	$151.46M+55.3%	$97.51M-17.8%	$118.65M+11.8%
Selling, general and administrative	$23.34M-1.2%	$23.62M+6.2%	$22.23M-0.2%	$22.28M-6.9%	$23.94M-10.3%
Total costs & expenses	$132.26M+18.1%	$111.99M-35.5%	$173.68M+45.2%	$119.63M-16.1%	$142.58M+10.1%
Operating income	-$132.29M-176%	-$47.92M+72.4%	-$173.44M-46.5%	-$118.42M+15.1%	-$139.55M-19.1%
Operating margin	456,172.4%+456,247pp	-74.8%+72,193pp	-72,267.9%-62,514pp	-9,754.3%-5,152pp	-4,602.5%-3,656pp
Other income (expense), net	$6.77M+39.2%	$4.86M-53.6%	$10.47M+37.2%	$7.63M-59.0%	$18.6M+49.1%
Income before income taxes	-$125.53M-192%	-$43.06M+73.6%	-$162.97M-47.1%	-$110.79M+8.4%	-$120.95M-15.5%
Income tax expense	$170K—	——	$168K-1.2%	$170K+963%	$16K+119%
Net income	-$125.7M-193%	-$42.92M+73.7%	-$163.14M-47.0%	-$110.96M+8.3%	-$120.97M-15.7%
Net margin	433,431%+433,498pp	-67%+67,908pp	-67,975.4%-58,836pp	-9,139.9%-5,150pp	-3,989.6%-3,144pp
Diluted earnings per share	-$0.85-183%	-$0.30+74.4%	-$1.17-46.2%	-$0.80+9.1%	-$0.88-15.8%
EBITDA	-$129.48M-188%	-$45.02M+73.6%	-$170.45M-47.6%	-$115.5M+15.5%	-$136.68M-19.6%
EBITDA margin	446,479.3%+446,550pp	-70.3%+70,948pp	-71,018.8%-61,505pp	-9,514%-5,006pp	-4,507.9%-3,584pp
EBIT	-$132.29M-176%	-$47.92M+72.4%	-$173.44M-46.5%	-$118.42M+15.1%	-$139.55M-19.1%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Vir Biotechnology, Inc.'s profit margins?: Gross margin is 96.1% and operating margin is -720.8%, with a -676.0% net margin.
Where does Vir Biotechnology, Inc.'s income statement data come from?: Every line is extracted from Vir Biotechnology, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.